| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD 20892-8115, USA
The TM2–TM3 extracellular loop is critical for activation of the Cys-loop family of ligand-gated ion channels. The contribution of aspartate 298 (D298), an amino acid that links the transmembrane domain 2 (TM2) to the TM2–TM3 loop, in mouse 5-hydroxytryptamine3A (5-HT3A) receptor function was probed with site-directed mutagenesis in the present study. This negatively charged residue was replaced with an alanine to neutralize the charge, with a glutamate to conserve the charge, or with an arginine to reverse the charge. Human embryonic kidney 293 (HEK 293) cells transfected with the wild-type and mutant receptors were studied by combining whole-cell patch-clamp recording with fast agonist application. The D
A or DR mutations resulted in a receptor with reduced 5-HT potency, and accelerated kinetics of desensitization and deactivation. In addition, the efficacy of partial agonists was reduced by the DA mutation. The DE mutation produced a receptor with properties similar to those of the wild-type receptor. In addition, the potential role of this residue in modulation of the receptor by extracellular calcium ([Ca2+]o) was investigated. Increasing [Ca2+]o inhibited 5-HT-activated currents and altered receptor kinetics in a similar manner in the wild-type and D298E receptors, and this alteration was eliminated by the DA and DR mutations. Our data suggest that the charge at D298 participates in transitions between functional states of the 5-HT3A receptor, and provide evidence that the charge of the side-chain at residue D298 contributes to channel gating kinetics and is crucial for Ca2+ modulation.
(Received 20 June 2005;
accepted after revision 5 August 2005;
first published online 11 August 2005)
Corresponding author D. M. Lovinger: Laboratory for Integrative Neuroscience, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, Room TS-13A, Bethesda, MD 20852, USA. Email: lovindav{at}mail.nih.gov
This article has been cited by other articles:
|
|
 |
|
  M. R. Livesey, M. A. Cooper, T. Z. Deeb, J. E. Carland, J. Kozuska, Tim. G. Hales, J. J. Lambert, and J. A. Peters Structural Determinants of Ca2+ Permeability and Conduction in the Human 5-Hydroxytryptamine Type 3A Receptor J. Biol. Chem., July 11, 2008; 283(28): 19301 - 19313. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X.-Q. Hu and R. W. Peoples The 5-HT3B Subunit Confers Spontaneous Channel Opening and Altered Ligand Properties of the 5-HT3 Receptor J. Biol. Chem., March 14, 2008; 283(11): 6826 - 6831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X.-Q. Hu and R. W. Peoples Arginine 246 of the Pretransmembrane Domain 1 Region Alters 2,2,2-Trichloroethanol Action in the 5-Hydroxytryptamine3A Receptor J. Pharmacol. Exp. Ther., March 1, 2008; 324(3): 1011 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xiong, M. Hosoi, B.-N. Koo, and L. Zhang Anandamide Inhibition of 5-HT3A Receptors Varies with Receptor Density and Desensitization Mol. Pharmacol., February 1, 2008; 73(2): 314 - 322. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Solt, D. Ruesch, S. A. Forman, P. A. Davies, and D. E. Raines Differential Effects of Serotonin and Dopamine on Human 5-HT3A Receptor Kinetics: Interpretation within an Allosteric Kinetic Model J. Neurosci., November 28, 2007; 27(48): 13151 - 13160. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
